TREACE MEDICAL CONCEPTS, INC. 8-K

What Happened

• Treace Medical Concepts, Inc. (TMCI) announced its financial results for the year ended December 31, 2025. The company issued a press release on February 27, 2026, and furnished that release as Exhibit 99.1 to a Current Report on Form 8‑K (Item 2.02). The 8‑K states the press release is incorporated by reference.

Key Details

• Filing date: February 27, 2026 (Form 8‑K filed with the SEC).
• Reporting period: Year ended December 31, 2025 (financial results announced for this period).
• Exhibit furnished: Exhibit 99.1 = press release dated February 27, 2026.
• Technical filing item: Item 2.02 (Results of Operations and Financial Condition); Exhibit 104 (Inline XBRL cover page data) included under Item 9.01.

Why It Matters

• The 8‑K formally notifies investors that TMCI reported its full‑year 2025 financial performance; investors should review the attached press release (Exhibit 99.1) for specific figures such as revenue, net income (or loss), margins, and any commentary on guidance or outlook.
• Because the filing itself furnishes the press release rather than embedding detailed tables in the 8‑K text, anyone evaluating the company’s earnings, revenue trends, or operating results should read the press release and any related filings (e.g., 10‑K or earnings slides) to see the full financial detail and management discussion.